Anti-COVID drug developed by DRDO for emergency use gets approved

Anti-COVID drug developed by DRDO for emergency use gets approved

All the patients who were treated with this showed faster symptomatic cure compared to the Standard of Care (SoC) on various endpoints. An anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been developed by Institute of Nuclear Medicine and Allied Sciences (INMAS). INMAS, a Defence Research and Development Organisation (DRDO), has along with Dr … Read more

Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

Coronavirus: DRDO’s anti-Covid drug 2-DG receives DCGI approval for emergency use

The second phase trial on average showed that patients administered with the drug recovered 2.5 days earlier than other patients. (Representative image) An anti-COVID-19 therapeutic drug developed by DRDO called drug2-deoxy-D-glucose (2-DG) has been given emergency approval by the Drug Controller General of India (DCGI) for Coronavirus patients in the country. The drug, which was … Read more